BSL-3 facility will aid fight against bioterrorism
Laboratory researchers may soon be better able to help fight bioterrorist
agents or infectious diseases that could be used against American citizens.
A new biosafety analytical laboratory took a step toward reality this
week when an environmental assessment was filed by the National Nuclear
Security Administration’s (NNSA) Oakland office.
Proposed for an area adjacent to Bldg. 361, the new facility would be
known as — and permit the use of organisms allowed in — a Biosafety
Level 3, or BSL-3 facility.
"This proposed facility," said Page Stoutland, deputy director
of R Division, "would allow our scientists to conduct more sophisticated
experiments on a wider array of microorganisms. We will be able to use
the unique capabilities of the Laboratory to help us develop much needed
biodetection capabilities. We’ll also be able to learn more about
new emerging diseases."
The proposed $1.5 million, 1,500 square-foot facility would include three
BSL-3 lab rooms and be built in accordance with guidelines by the Centers
for Disease Control and Prevention (CDC) and the National Institutes of
Health. It would be operated primarily by the Biology and Biotechnology
Research Program directorate (BBRP) for another Lab directorate, Nonproliferation,
Arms Control and International Security (NAI).
The Laboratory has been asked by the CDC to develop DNA signatures for
a number of pathogens to improve detection and understanding of those
diseases.
However, as the Laboratory currently does not have a BSL-3 facility —
and can’t work with live organisms designated for use in such facilities
— the work of Livermore scientists for countering terrorism and some
infectious diseases is slowed, according to Bert Weinstein, acting associate
director for the Biology and Biotechnology Research Program, or BBRP.
For a number of years, Lab scientists have conducted research — and
operated — biomedical facilities at the lower levels of biosafety
one and two. The previous research by Livermore scientists has already
proven valuable in the development of DNA signatures that speed detection
of various microorganisms and can help save lives.
This research is done in collaboration with Los Alamos National Laboratory,
the CDC, the Department of Defense and the U.S. Department of Agriculture.
Two examples of DNA signatures developed through this process are for
Bacillus anthracis, the bacteria that causes anthrax, and Yersinia pestis,
the bacteria that causes plague. Both plague and anthrax can be produced
for criminal purposes or occur as natural diseases.
To conduct research on other organisms, such as valley fever and rabbit
fever, Lab scientists have had to travel to other BSL-3 facilities in
California and even other states, Weinstein noted.
"Since we started working with plague and anthrax in our existing
BSL-2 facility we have found we can progress two to three times faster
in developing tests for detecting pathogens than we could before,"
Weinstein said.
Once DNA signatures developed by Livermore scientists and other researchers
are approved by the CDC, they are then distributed to public health laboratories
around the nation.
The first use of a Livermore DNA signature to detect a public health disease
in the environment took place in May 2001 when plague was found in a small
community northwest of Flagstaff, Arizona.
Naturally-occurring outbreaks of plague often hit the Southwest region
of the U.S., particularly Arizona and New Mexico, in the spring and summer
months. While tests for plague have usually required seven to 10 days
to confirm, the Lab’s DNA signatures — used by Northern Arizona
University researchers — confirmed the presence of the disease within
four hours. Rapid detection of plague can save lives, as the survival
rate of the disease is nearly 100 percent with the prompt treatment of
antibiotics.
"With DNA signatures, we are working toward faster identification
of these diseases, some of which, like anthrax, have symptoms that can
be confused with the flu," Weinstein said.
With a BSL-3 facility, Lab researchers could have access to small amounts
of the microorganisms that cause two diseases endemic to California —
valley fever and rabbit fever.
Lab scientists plan to develop a DNA signature for Francisella tularensis,
the bacteria that causes rabbit fever and is named for Tulare County.
"Since 2000, Lab researchers have worked with a number of strains
of anthrax and plague for the NNSA’s Chemical and Biological National
Security Program, Weinstein said, adding the work has been conducted safely
and in full compliance all applicable security, health and other administrative
requirements and guidelines.
"We now have the track record and trained personnel that make us
confident we can conduct high-quality and safe research with a BSL-3 facility,"
he said.
The environmental assessment process, which opened Wednesday, runs until
Aug. 23. If there is a determination that the BSL-3 facility would have
a minimal impact, the project could go out to bid in September or October
and be built by March or April, 2003.
One of the options being strongly considered for a Livermore BSL-3 facility
is be to purchase a pre-fabricated building. These buildings are available
from a number of different manufacturers.